V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002858 | 210008628 | 1.56 | 53.2 | Palliative (P) | null | 2020-04-13 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100017670 |
| 210002859 | 210008629 | null | 71 | null | null | 2018-12-16 | Docetaxel | 02 | null | DOCETAXEL | 100814918 |
| 210002861 | 210008630 | 1.76 | 90.5 | Adjuvant (A) | 2018-06-08 | 2018-06-10 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101578111 |
| 210002863 | 210008632 | 1.62 | 86.7 | Neo-adjuvant (N) | null | 2020-01-27 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100688876 |
| 210002864 | 210008633 | null | 69.4 | null | 2018-11-24 | 2019-01-08 | Trastuzumab | 02 | null | TRASTUZUMAB | 100450036 |
| 210002866 | 210008635 | null | null | Adjuvant (A) | 2020-12-28 | 2021-04-06 | Docetaxel 75mg/m2 (21 day) | null | N | DOCETAXEL | 100546845 |
| 210002869 | 210008637 | 1.69 | 54 | Adjuvant (A) | null | 2020-04-22 | Trastuzumab Subcutaneous | N | N | TRASTUZUMAB | 101557634 |
| 210002870 | 210008638 | 1.7 | 68.55 | Adjuvant (A) | 2018-09-18 | 2018-12-11 | Docetaxel | 02 | N | DOCETAXEL | 100198080 |
| 210002872 | 210008640 | null | 61.5 | null | 2016-09-03 | 2016-12-11 | Docetaxel | null | null | DOCETAXEL | 100224710 |
| 210002878 | 210008644 | 1.63 | null | Adjuvant (A) | 2016-10-20 | 2016-10-27 | Trastuzumab | 02 | N | TRASTUZUMAB | 101006110 |
| 210002880 | 210008646 | null | null | Curative (C) | 2020-02-03 | 2020-03-18 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100257081 |
| 210002884 | 210008648 | 1.56 | 57.5 | Adjuvant (A) | null | 2017-07-04 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100946010 |
| 210002886 | 210008649 | 1.68 | 115.2 | Neo-adjuvant (N) | 2016-12-19 | 2017-01-03 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100675150 |
| 210002887 | 210008650 | 0 | 93 | null | 2019-04-03 | 2019-04-05 | Docetaxel | null | null | DOCETAXEL | 101533304 |
| 210002891 | 210008652 | 1.68 | 56.9 | Adjuvant (A) | 2016-12-17 | 2017-03-09 | Paclitaxel 7 day | null | N | PACLITAXEL | 101792681 |
| 210002892 | 210008653 | 1.58 | 98.5 | Neo-adjuvant (N) | 2018-11-13 | 2018-11-20 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101089523 |
| 210002893 | 210008654 | 1.72 | 84.9 | Curative (C) | null | 2019-02-11 | Docetaxel | 02 | N | DOCETAXEL | 100497400 |
| 210002894 | 210008655 | 1.58 | 85.8 | Adjuvant (A) | null | 2018-02-20 | TRASTUZUMAB | N | N | TRASTUZUMAB | 101100211 |
| 210002895 | 210008656 | null | 66.1 | null | 2017-04-18 | 2017-07-31 | Docetaxel | N | null | DOCETAXEL | 101293646 |
| 210002898 | 210008657 | 1.54 | 70.1 | Adjuvant (A) | 2018-06-16 | 2018-09-15 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100974758 |
| 210002899 | 210008658 | 1.68 | 84.1 | Neo-adjuvant (N) | 2019-12-13 | 2020-02-28 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101464667 |
| 210002900 | 210008659 | 1.54 | 88.3 | Neo-adjuvant (N) | 2017-02-14 | 2017-05-08 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100015149 |
| 210002904 | 210008661 | 1.73 | 87.1 | Curative (C) | 2017-03-09 | 2017-06-28 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100036885 |
| 210002905 | 210008662 | 1.7 | 106.9 | null | null | 2019-09-14 | TRASTUZUMAB | null | null | TRASTUZUMAB | 101028049 |
| 210002906 | 210008663 | 1.77 | 122.2 | Palliative (P) | 2018-06-09 | 2018-08-20 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100885329 |
| 210002908 | 210008664 | null | 86.4 | Not known (9) | 2017-05-15 | 2018-08-05 | Docetaxel | 02 | N | DOCETAXEL | 100285598 |
| 210002910 | 210008665 | 1.65 | 89 | Palliative (P) | null | 2018-07-11 | Docetaxel | 02 | N | DOCETAXEL | 100774139 |
| 210002911 | 210008666 | 1.58 | 49.9 | Neo-adjuvant (N) | 2016-07-11 | 2016-08-01 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101261700 |
| 210002912 | 210008667 | 1.66 | 78.3 | Palliative (P) | null | 2019-04-02 | Docetaxel 75mg/m2 (21 day) | null | N | DOCETAXEL | 101686428 |
| 210002915 | 210008669 | 1.52 | 77 | Adjuvant (A) | null | 2020-03-12 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101163156 |
| 210002920 | 210008672 | 1.69 | null | null | 2017-12-06 | 2018-06-25 | EC | N | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101155828 |
| 210002921 | 210008673 | null | 55.4 | null | 2019-06-18 | 2019-06-28 | Docetaxel 75mg/m2 (21 day) | null | N | DOCETAXEL | 101822744 |
| 210002922 | 210008674 | 1.63 | 70.8 | Adjuvant (A) | null | 2017-11-18 | Docetaxel | 02 | N | DOCETAXEL | 100940930 |
| 210002924 | 210008675 | 1.68 | 68.55 | Adjuvant (A) | 2016-12-31 | 2017-03-05 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101550346 |
| 210002925 | 210008676 | 1.65 | 87 | Palliative (P) | null | 2022-05-10 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101151301 |
| 210002926 | 210008677 | 1.57 | 59.4 | Adjuvant (A) | 2016-01-11 | 2016-05-09 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101170018 |
| 210002927 | 210008678 | 1.67 | 89.8 | Adjuvant (A) | 2021-02-22 | 2021-03-23 | Trastuzumab | 02 | N | TRASTUZUMAB | 100597936 |
| 210002931 | 210008681 | 1.66 | 103 | Neo-adjuvant (N) | 2018-10-25 | 2018-11-16 | Docetaxel | 02 | N | DOCETAXEL | 101273592 |
| 210002932 | 210008682 | 1.61 | 65.4 | Adjuvant (A) | 2018-12-25 | 2019-05-09 | Docetaxel | 02 | N | DOCETAXEL | 100613122 |
| 210002935 | 210008683 | 1.63 | 106.4 | Palliative (P) | 2018-11-07 | 2018-11-17 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100668526 |
| 210002937 | 210008684 | 1.74 | 79 | Palliative (P) | 2019-09-30 | 2019-12-16 | Docetaxel | null | N | DOCETAXEL | 101655869 |
| 210002939 | 210008685 | 1.53 | 72.6 | Neo-adjuvant (N) | 2017-03-29 | 2017-06-07 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | PACLITAXEL | 101686502 |
| 210002941 | 210008686 | 1.65 | 56.2 | null | 2017-05-16 | 2017-05-16 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100371653 |
| 210002942 | 210008687 | null | 88.7 | null | null | 2017-05-31 | Docetaxel | null | null | DOCETAXEL | 101053988 |
| 210002944 | 210008689 | 1.62 | 72.2 | Neo-adjuvant (N) | null | 2018-02-15 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101520382 |
| 210002949 | 210008690 | 1.54 | 75.4 | Adjuvant (A) | 2018-11-19 | 2018-12-01 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101762703 |
| 210002951 | 210008691 | null | null | Palliative (P) | 2017-07-29 | 2017-10-02 | Docetaxel | 02 | N | DOCETAXEL | 100080202 |
| 210002956 | 210008693 | null | null | null | 2016-12-14 | 2017-01-11 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100256975 |
| 210002957 | 210008694 | null | null | null | 2016-08-15 | 2016-09-03 | null | null | null | EPIRUBICIN | 101563075 |
| 210002959 | 210008696 | null | null | null | 2019-10-17 | 2019-10-17 | TCH (21 day Trastuzumab) Maint | 02 | null | LETROZOLE + PALBOCICLIB | 101277081 |